FNY Investment Advisers’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

FNY Investment Advisers’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-46,187	Closed	-$32K	–	764
2023 Q1	$32K	Buy	+46,187	New	+$42.5K	0.04%	220
2019 Q4	–	Sell	-300	Closed	-$4K	–	1126
2019 Q3	$4K	Buy	+300	New	+$4.65K	﹤0.01%	676

FNY Investment Advisers's STSA Position: Q2 2023 in Review

FNY Investment Advisers sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 46,187 shares — an estimated $32K sold.

FNY Investment Advisers first reported a position in STSA in Q3 2019 and held it in 2 quarters. The position peaked at $32K in Q1 2023. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.

FNY Investment Advisers reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
FNY Investment Advisers sold 46,187 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $32K.
FNY Investment Advisers first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
FNY Investment Advisers's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $32K in Q1 2023.
0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on FNY Investment Advisers's 13F filing for Q2 2023, filed 11 Jul 2023.